Vaccine for the deadly disease Coronavirus is now on the 3rd phase of the trial in India. Bharat Biotech has taken over the responsibility, Officially they have announced the information about the 3rd trial of the vaccine.
Bharat Biotech has said that around 26000 volunteers will be the part of trial in across the country, and it will be conducted in partnership of ICMR ( Indian Council of Medical Research). Reports says that this trial would be the largest clinical trial for Covid-19 vaccine in India. The age of the volunteers would be 18. The volunteers who are below 18 they can not be part of the trial.
Drugs Controller General of India has given green signal to this trial. All the process will be done very carefully so that it will not affect any volunteer.
Bharat Biotech says that the volunteers will receive two intramuscular injections approximately 28 days apart. All the participants will be randomly assigned to receive Covaxin or placebo. The trial is double blinded, such that the investigators, the participants and the company will not be aware of who is assigned to which group. Covaxin has been evaluated in 1000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity data.
The trials are being conducted at 22 institutes in India including the All India Institute of Medical Sciences (AIIMS), the Guru Tegh Bahadur Hospital (both New Delhi), the Aligarh Muslim University, the Grant Government Medical College and Sir J.J. Group of Hospitals, Lokmanya Tilak Municipal General Hospital and Medical College (Sion Hospital) (all three Mumbai), the ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, the Directorate of Public Health and Preventive Medicine, Chennai and King George Hospital, Vizag.
There will be people to keep an eye on the volunteers so that they take all the precautions as well as all of them will be in a good health condition. The duration of vaccine is not declared yet. Bharat Biotech officially have not given any statement on this. But as it is a trial with a group of thousand people in 22 different institution so the trial will be a bit longer.